Treatment of multiple system atrophy using intravenous immunoglobulin

BACKGROUND: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia. Disease-modifying therapies are unavailable. Activation of microglia and production of toxic cytokines suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Peter, Williams, Arlene, Ravin, Paula, Zurkiya, Omar, Abduljalil, Amir, Novak, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551813/
https://www.ncbi.nlm.nih.gov/pubmed/23116538
http://dx.doi.org/10.1186/1471-2377-12-131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551813/
https://www.ncbi.nlm.nih.gov/pubmed/23116538
http://dx.doi.org/10.1186/1471-2377-12-131

Ejemplares similares